AAAAAA

   
Results: 1-12 |
Results: 12
Regional mucociliary clearance in patients with cystic fibrosis
Authors: Robinson, M Eberl, S Tomlinson, C Daviskas, E Regnis, JA Bailey, DL Torzillo, PJ Menache, M Bye, PT
Citation: M. Robinson et al., Regional mucociliary clearance in patients with cystic fibrosis, J AEROSOL M, 13(2), 2000, pp. 73-86
Does attenuation correction work?
Authors: Bailey, DL Meikle, SR
Citation: Dl. Bailey et Sr. Meikle, Does attenuation correction work?, J NUCL MED, 41(5), 2000, pp. 960-961
Physical characteristics of the ECAT EXACT3D positron tomograph
Authors: Spinks, TJ Jones, T Bloomfield, PM Bailey, DL Miller, M Hogg, D Jones, WF Vaigneur, K Reed, J Young, J Newport, D Moyers, C Casey, ME Nutt, R
Citation: Tj. Spinks et al., Physical characteristics of the ECAT EXACT3D positron tomograph, PHYS MED BI, 45(9), 2000, pp. 2601-2618
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives
Authors: Sall, DJ Bailey, DL Bastian, JA Buben, JA Chirgadze, NY Clemens-Smith, AC Denney, ML Fisher, MJ Giera, DD Gifford-Moore, DS Harper, RW Johnson, LM Klimkowski, VJ Kohn, TJ Lin, HS McCowan, JR Palkowitz, AD Richett, ME Smith, GF Snyder, DW Takeuchi, K Toth, JE Zhang, MS
Citation: Dj. Sall et al., Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives, J MED CHEM, 43(4), 2000, pp. 649-663
Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of invivo efficacy
Authors: Zhang, MS Bailey, DL Bastian, JA Briggs, SL Chirgadze, NY Clawson, DK Denney, ML Gifford-Moore, DS Harper, RW Johnson, LM Klimkowski, VJ Kohn, TJ Lin, HS McCowan, JR Richett, ME Sall, DJ Smith, AJ Smith, GF Snyder, DW Takeuchi, K Utterback, BG Yan, SCB
Citation: Ms. Zhang et al., Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of invivo efficacy, BIOORG MED, 9(5), 1999, pp. 775-780
Randoms variance reduction in 3D PET
Authors: Badawi, RD Miller, MP Bailey, DL Marsden, PK
Citation: Rd. Badawi et al., Randoms variance reduction in 3D PET, PHYS MED BI, 44(4), 1999, pp. 941-954
Statistical parametric mapping with F-18-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
Authors: Ito, K Morrish, PK Rakshi, JS Uema, T Ashburner, J Bailey, DL Friston, KJ Brooks, DJ
Citation: K. Ito et al., Statistical parametric mapping with F-18-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease, J NE NE PSY, 66(6), 1999, pp. 754-758
A dimeric form of Escherichia coli succinyl-CoA synthetase produced by site-directed mutagenesis
Authors: Bailey, DL Fraser, ME Bridger, WA James, MNG Wolodko, WT
Citation: Dl. Bailey et al., A dimeric form of Escherichia coli succinyl-CoA synthetase produced by site-directed mutagenesis, J MOL BIOL, 285(4), 1999, pp. 1655-1666
Investigation of the scatter contribution in single photon transmission measurements by means of Monte Carlo simulations
Authors: Wegmann, K Adam, LE Livieratos, L Zaers, J Bailey, DL Brix, G
Citation: K. Wegmann et al., Investigation of the scatter contribution in single photon transmission measurements by means of Monte Carlo simulations, IEEE NUCL S, 46(4), 1999, pp. 1184-1190
Chemistry turnaround time - Response
Authors: Bailey, DL
Citation: Dl. Bailey, Chemistry turnaround time - Response, LAB MED, 30(3), 1999, pp. 152-153
Frontal, midbrain and striatal dopaminergic function in early and advancedParkinson's disease A 3D [F-18]dopa-PET study
Authors: Rakshi, JS Uema, T Ito, K Bailey, DL Morrish, PK Ashburner, J Dagher, A Jenkins, IH Friston, KJ Brooks, DJ
Citation: Js. Rakshi et al., Frontal, midbrain and striatal dopaminergic function in early and advancedParkinson's disease A 3D [F-18]dopa-PET study, BRAIN, 122, 1999, pp. 1637-1650
I need to see it to believe it - Response
Authors: Bailey, DL
Citation: Dl. Bailey, I need to see it to believe it - Response, LAB MED, 29(12), 1998, pp. 727-727
Risultati: 1-12 |